JPRN-jRCTs031200114招募中未知
A pilot study to assess the safety of the ICG angiography for the evaluation of lymph duct morphology and function before and after pelvic lymphadenectomy in patients with gynecologic cancers.
Hirayama Takashi0 个研究点目标入组 30 人开始时间: 2020年9月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •1) Age>20 years old, Sex: female
- •2) Cervical cancer or Corpus cancer or Ovarian cancer
- •3) Pelvic lymphadenectomy is scheduled.
- •4) Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2
- •5) Written informed consent
- •6) Adequate organ function (especially in bone marrow, liver and kidney): Meet the criteria as below within 14 days before registration.
- •1. WBC >= 3000 /mm3 and Neutrophil > 1500mm3
- •2. Platelet > 100,000/ mm3
- •3. AST, ALT < 2.5 times lower than the normal range
- •4. Total bilirubin < 1.5 times lower than the normal range
- •5. Serum albumin > 2.8g/dl
- •6. Serum creatinine < 1.5 times lower than the normal range
排除标准
- •1)History of radiation therapy
- •2)History of chemotherapy
- •3)Allergy to ICG
- •4)Allergy to iodine
- •5)Others who are not suitable for this research
研究者
相似试验
已完成
1 期
A clinical trial of SIIL's H1N1 vaccine (Inactivated) in Adults.CTRI/2010/091/000082Serum Institute of India Limited SII50
招募中
1 期
A pilot study to characterize the safety and infectivity of a Plasmodium knowlesi parasite bank in healthy volunteersInfection - Other infectious diseasesMalariaACTRN12623001326684QIMR Berghofer Medical Research Institute4
已完成
1 期
A pilot study to characterise the in vivo safety and infectivity of a Plasmodium falciparum 3D7-GL master cell bank in healthy subjectsInfection - Other infectious diseasesMalariaACTRN12619001085167QIMR Berghofer Medical Research Institute2
尚未招募
2 期
Clinical study of nutritional supplement Supply6 360 to improve gut health.CTRI/2024/03/063507Kanari Nutrition Pvt. Ltd.
已完成
1 期
A Phase Ib Study of Pembrolizumab in Combination with Cisplatin and Pemetrexed in Advanced MPMJPRN-jRCT2080224966MSD K.K.18